| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate |
2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57066585839c4379fa0a78c480dd4654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e85fb5bf0a967db41bd4a952d922b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8460cc7838e1b7ace050893ed5cba394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3452b3182b2f43d5ace7ac75bfeb86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0f87e88fb0b563191a4e05afe3dd9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29090a16023513325a3377ba656d17c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4ff3d79cb3f6329e50a0a4e2dfd7b23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd960de91b9e86566dd5fa031fd9a43 |
| publicationDate |
2021-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3254680-B1 |
| titleOfInvention |
Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compound |
| priorityDate |
2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |